Inoviq Ltd (IIQ) Price & Analysis

Compare

1 Followers

IIQ Stock Chart & Stats

Day’s Range― - ―

52-Week RangeAU$0.35 - AU$0.69

Previous CloseN/A

Volume76.26K

Average Volume (3M)394.19K

Market Cap

AU$40.75M

Enterprise ValueN/A

Total Cash (Recent Filing)AU$9.23M

Total Debt (Recent Filing)AU$403.74K

Price to Earnings (P/E)―

Beta0.40

Next Earnings

Sep 02, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding111,632,805

10 Day Avg. Volume167,983

30 Day Avg. Volume394,192

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.50

Price Target Upside42.86% Upside

Rating ConsensusHold

Number of Analyst Covering1

Inoviq Ltd News

PremiumCompany Announcements

INOVIQ Ltd to Host Investor Briefing on Cancer Diagnostics and Therapeutics

19h ago

PremiumCompany Announcements

INOVIQ’s New Cancer Treatment Shows Promising Lab Results

17d ago

PremiumCompany Announcements

INOVIQ’s Breakthrough Cancer Treatment Shows 88% Efficacy in Lab Tests

22d ago

PremiumCompany Announcements

Inoviq Ltd Trading Suspension Lifted Amid ASX Compliance Enquiries

1M ago

PremiumCompany Announcements

INOVIQ’s Breakthrough in Early Ovarian Cancer Screening

1M ago

PremiumCompany Announcements

Inoviq Ltd Securities Suspended from ASX Quotation

1M ago

PremiumCompany Announcements

INOVIQ Clarifies ASX Query and Highlights Upcoming ASCO Presentation

1M ago

PremiumCompany Announcements

INOVIQ Ltd Requests Trading Halt Pending Key Announcement

1M ago

See All AU:IIQ News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

6.10% Insiders

―

Mutual Funds

― Other Institutional Investors

93.90% Public Companies and

Individual Investors

Detailed Ownership Overview >

IIQ FAQ

What was Inoviq Ltd’s price range in the past 12 months?

Inoviq Ltd lowest share price was AU$0.34 and its highest was AU$0.69 in the past 12 months.

What is Inoviq Ltd’s market cap?

Inoviq Ltd’s market cap is AU$40.75M.

When is Inoviq Ltd’s upcoming earnings report date?

Inoviq Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 54 days.

How were Inoviq Ltd’s earnings last quarter?

Inoviq Ltd released its earnings results on Feb 20, 2025. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.033.

Is Inoviq Ltd overvalued?

According to Wall Street analysts Inoviq Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Inoviq Ltd pay dividends?

Inoviq Ltd does not currently pay dividends.

What is Inoviq Ltd’s EPS estimate?

Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Inoviq Ltd have?

Inoviq Ltd has 111,632,805 shares outstanding.

What happened to Inoviq Ltd’s price movement after its last earnings report?

Inoviq Ltd reported an EPS of -AU$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Inoviq Ltd?

Currently, no hedge funds are holding shares in AU:IIQ

Inoviq Ltd Stock Smart Score

Underperform

Fundamentals

Return on Equity

-39.07%

Trailing 12-Months

Asset Growth

15.05%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Inoviq Ltd

Inoviq Ltd (IIQ) is a biotechnology company specializing in the development and commercialization of diagnostic and prognostic products for cancer and other diseases. The company operates in the healthcare sector, focusing on providing innovative solutions that improve patient outcomes through early detection and monitoring of diseases. Inoviq's core products include a range of diagnostic tests that leverage proprietary technologies to offer high accuracy and reliability in clinical applications.

IIQ Stock 12 Month Forecast

Average Price Target

AU$0.50

▲(42.86%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","-1":"-AU$1","-0.5":"-AU$0.5","0.5":"AU$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.56,0.5553846153846155,0.5507692307692308,0.5461538461538462,0.5415384615384615,0.536923076923077,0.5323076923076924,0.5276923076923077,0.5230769230769231,0.5184615384615385,0.5138461538461538,0.5092307692307693,0.5046153846153846,{"y":0.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.56,0.5553846153846155,0.5507692307692308,0.5461538461538462,0.5415384615384615,0.536923076923077,0.5323076923076924,0.5276923076923077,0.5230769230769231,0.5184615384615385,0.5138461538461538,0.5092307692307693,0.5046153846153846,{"y":0.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.56,0.5553846153846155,0.5507692307692308,0.5461538461538462,0.5415384615384615,0.536923076923077,0.5323076923076924,0.5276923076923077,0.5230769230769231,0.5184615384615385,0.5138461538461538,0.5092307692307693,0.5046153846153846,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.56,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.63,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.56,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.48,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.46,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.46,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.52,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.46,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.42,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.4,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.4,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.4,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.56,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >